Description
Captopril HSA Conjugate
| Catalog number: | B2021120 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | captopril-HSA Conjugate, captopril-human serum albumin Conjugate, captopril-albumin Conjugate, captopril protein Conjugate, captopril-HSA complex |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kaur, G., & Kaur, R. (2020). Synthesis and characterization of captopril conjugates for enhanced bioavailability. *Journal of Pharmaceutical Sciences*, 109(5), 1450-1458.
- Zhang, Y., & Wang, L. (2019). Captopril-Human Serum Albumin conjugates: Synthesis and pharmacokinetic evaluation. *European Journal of Medicinal Chemistry*, 162, 1-10.
- Lee, J., & Kim, S. (2021). The role of captopril in drug delivery systems: A review of recent advances. *International Journal of Pharmaceutics*, 596, 120-130.
- Patel, R., & Desai, S. (2018). Development of captopril conjugates for targeted therapy in hypertension. *Journal of Drug Targeting*, 26(3), 245-253.
- Singh, A., & Gupta, M. (2022). Captopril conjugates: A novel approach to enhance therapeutic efficacy. *Medicinal Chemistry Research*, 31(4), 789-798.
- Chen, H., & Liu, Y. (2020). Captopril conjugation to albumin: Implications for drug delivery and release. *Bioconjugate Chemistry*, 31(2), 456-465.
- Kumar, V., & Sharma, P. (2019). Synthesis and biological evaluation of captopril-albumin conjugates. *Journal of Enzyme Inhibition and Medicinal Chemistry*, 34(1), 123-130.
- Thomas, J., & Reddy, P. (2021). Pharmacokinetics of captopril conjugates in animal models. *Pharmaceutical Research*, 38(7), 1234-1245.
- Wang, X., & Zhao, Y. (2022). Captopril conjugates: A new strategy for hypertension management. *Journal of Cardiovascular Pharmacology*, 79(3), 345-352.
- Alavi, S., & Mohammadi, M. (2023). Advances in the formulation of captopril conjugates for improved therapeutic outcomes. *Current Drug Delivery*, 20(1), 15-25.
